Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MC-1101 in Nonexudative AMD
NCT01601483Phase 3Terminated
- Sponsor
- MacuCLEAR
- Start
- Oct 2012
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydralazine in age-related macular degeneration (AMD), sponsored by MacuCLEAR. Started Oct 2012; status: terminated.
02
Drugs
hydralazine
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT01601483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01601483.